BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22886417)

  • 1. β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury.
    Kim KS; Abraham D; Williams B; Violin JD; Mao L; Rockman HA
    Am J Physiol Heart Circ Physiol; 2012 Oct; 303(8):H1001-10. PubMed ID: 22886417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium.
    Monasky MM; Taglieri DM; Henze M; Warren CM; Utter MS; Soergel DG; Violin JD; Solaro RJ
    Am J Physiol Heart Circ Physiol; 2013 Sep; 305(6):H856-66. PubMed ID: 23873795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
    Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
    J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Arrestin mediates the Frank-Starling mechanism of cardiac contractility.
    Abraham DM; Davis RT; Warren CM; Mao L; Wolska BM; Solaro RJ; Rockman HA
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14426-14431. PubMed ID: 27911784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac myosin light chain phosphorylation and inotropic effects of a biased ligand, TRV120023, in a dilated cardiomyopathy model.
    Tarigopula M; Davis RT; Mungai PT; Ryba DM; Wieczorek DF; Cowan CL; Violin JD; Wolska BM; Solaro RJ
    Cardiovasc Res; 2015 Jul; 107(2):226-34. PubMed ID: 26045475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proximal tubule NHE3 activity is inhibited by beta-arrestin-biased angiotensin II type 1 receptor signaling.
    Carneiro de Morais CP; Polidoro JZ; Ralph DL; Pessoa TD; Oliveira-Souza M; Barauna VG; Rebouças NA; Malnic G; McDonough AA; Girardi AC
    Am J Physiol Cell Physiol; 2015 Oct; 309(8):C541-50. PubMed ID: 26246427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.
    Violin JD; DeWire SM; Yamashita D; Rominger DH; Nguyen L; Schiller K; Whalen EJ; Gowen M; Lark MW
    J Pharmacol Exp Ther; 2010 Dec; 335(3):572-9. PubMed ID: 20801892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biased Agonism of the Angiotensin II Type I Receptor.
    Ikeda Y; Kumagai H; Motozawa Y; Suzuki J; Komuro I
    Int Heart J; 2015; 56(5):485-8. PubMed ID: 26180022
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Wang J; Pani B; Gokhan I; Xiong X; Kahsai AW; Jiang H; Ahn S; Lefkowitz RJ; Rockman HA
    Mol Pharmacol; 2021 Dec; 100(6):568-579. PubMed ID: 34561298
    [No Abstract]   [Full Text] [Related]  

  • 10. β-Arrestin-Biased Agonist Targeting the Brain AT
    Zanaty M; Seara FAC; Nakagawa P; Deng G; Mathieu NM; Balapattabi K; Karnik SS; Grobe JL; Sigmund CD
    Hypertension; 2021 Feb; 77(2):420-431. PubMed ID: 33249862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanoactivation of the angiotensin II type 1 receptor induces β-arrestin-biased signaling through Gα
    Wang J; Hanada K; Gareri C; Rockman HA
    J Cell Biochem; 2018 Apr; 119(4):3586-3597. PubMed ID: 29231251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure.
    Boerrigter G; Lark MW; Whalen EJ; Soergel DG; Violin JD; Burnett JC
    Circ Heart Fail; 2011 Nov; 4(6):770-8. PubMed ID: 21835984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
    Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure.
    Boerrigter G; Soergel DG; Violin JD; Lark MW; Burnett JC
    Circ Heart Fail; 2012 Sep; 5(5):627-34. PubMed ID: 22891045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT
    Teixeira LB; Parreiras-E-Silva LT; Bruder-Nascimento T; Duarte DA; Simões SC; Costa RM; Rodríguez DY; Ferreira PAB; Silva CAA; Abrao EP; Oliveira EB; Bouvier M; Tostes RC; Costa-Neto CM
    Sci Rep; 2017 Sep; 7(1):11903. PubMed ID: 28928410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Biased β-Arrestin Signaling Improves Cardiac Structure and Function in Dilated Cardiomyopathy.
    Ryba DM; Li J; Cowan CL; Russell B; Wolska BM; Solaro RJ
    Circulation; 2017 Mar; 135(11):1056-1070. PubMed ID: 28104714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling.
    Grisanti LA; Thomas TP; Carter RL; de Lucia C; Gao E; Koch WJ; Benovic JL; Tilley DG
    Theranostics; 2018; 8(17):4664-4678. PubMed ID: 30279730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms.
    Bathgate-Siryk A; Dabul S; Pandya K; Walklett K; Rengo G; Cannavo A; De Lucia C; Liccardo D; Gao E; Leosco D; Koch WJ; Lymperopoulos A
    Hypertension; 2014 Feb; 63(2):404-12. PubMed ID: 24218435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
    Ferraino KE; Cora N; Pollard CM; Sizova A; Maning J; Lymperopoulos A
    Cell Signal; 2021 Jun; 82():109967. PubMed ID: 33640432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
    Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.